Life Spine receives FDA 510(k) clearance for Longbow titanium lateral expandable spacer system

219

Life Spine has received clearance from the US Food and Drug Administration (FDA) to market the Longbow titanium lateral expandable spacer system.

The Longbow system is available in lengths ranging from 45–60mm, heights from 9mm–15mm, 0 degrees and 7 degrees lordotic options and widths that expand from 15–27mm anterior to posterior.

Longbow can be post-packed after expansion in-situ with up to 11cc of graft to fill the implant and features Life Spine’s proprietary Osseo-Loc surface technology.

“We are thrilled to be releasing a Titanium version of the first to market Longbow expandable lateral spacer system which was designed to accomplish previously unmet surgical goals,” said Rich Mueller, chief operating officer for Life Spine. “The spacer is able to achieve up to 12mm of anterior to posterior expansion allowing for a contracted insertion size of 15mm, but once expanded can boast a footprint closer to that of an ALIF spacer as opposed to a traditional lateral spacer.”


LEAVE A REPLY

Please enter your comment!
Please enter your name here